中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 6
Jun.  2016

Simple serum markers for significant liver inflammation in chronic hepatitis B patients with an alanine aminotransferase level lower than 2 times upper limit of normal

DOI: 10.3969/j.issn.1001-5256.2016.06.021
Research funding:

 

  • Published Date: 2016-06-20
  • Objective To investigate the simple serum markers for significant liver inflammation in chronic hepatitis B(CHB) patients with an alanine aminotransferase(ALT) level of < 2 times upper limit of normal(ULN).Methods The clinical data of 278 CHB patients with ALT < 2 × ULN(ULN = 40 U / L) were analyzed retrospectively.Significant liver inflammation was defined as a liver inflammatory activity grade(G) ≥2.The t- test was used for comparison of normally distributed continuous data between groups,and the Kruskal- Wallis rank sum test was used for non- normally distributed continuous data;the chi- square test was used for comparison of categorical data between groups.Multivariate logistic regression analysis was used to identify independent predictors for significant liver inflammation in CHB patients with ALT < 2 × ULN.The receiver operating characteristic(ROC) curve was used to evaluate the diagnostic value of serum markers in significant liver inflammation.Results Of the 278 CHB patients enrolled,175(62.9%) had no significant liver inflammation(G0- 1group) and 103(37.1%) had significant liver inflammation(G2- 4 group).There were significant differences in ALT,aspartate aminotransferase,alkaline phosphatase,gamma- glutamyl transpeptidase(GGT),albumin,globulin,prothrombin time(PT),platelet,absolute neutrophil count,hyaluronic acid(HA),glycocholic acid,precollagen Ⅲ,and collagen type Ⅳ(ⅣC) between the two groups(all P< 0.05).The multivariate regression analysis showed that GGT,PT,ⅣC,and HA were independent predictors for significant liver inflammation in CHB patients with ALT < 2 × ULN(OR = 1.015,1.600,1.151,and 1.014,P = 0.008,0.021,0.003,and 0.018).The areas under the ROC curve for GGT,PT,IVC,and HA to diagnose significant liver inflammation were 0.804,0.722,0.707,and 0.632,respectively.The cut- off value of 48.5 U / L for GGT to predict significant liver inflammation had a specificity of 90.3% and a negative predictive value of 74.6%.Conclusion GGT,PT,IVC,and HA are independent predictors for significant liver inflammation in CHB patients with ALT < 2 × ULN,among which GGT has the highest predictive value.

     

  • [1] RAPTOPOULOU M,PAPATHEODORIDIS G,ANTONIOU A,et al.Epidemiology,course and disease burden of chronic hepatitis Bvirus infection.HEPNET study for chronic hepatitis B:a multicentre Greek study[J].J Viral Hepat,2009,16(3):195-202.
    [2]LIANG P,ZU J,YIN J,et al.The independent impact of newborn hepatitis B vaccination on reducing HBV prevalence in China,1992-2006:a mathematical model analysis[J].J Theor Biol,2015,386:115-121.
    [3]GUO TZ,HAN LX,LUO Y,et al.Risk factors of liver cancer in patients with hepatitis B virus infection[J].Int J Virol,2016,23(1):26-28.(in Chinese)郭铁志,韩立新,罗研,等.乙型肝炎病毒感染患者肝癌发病的影响因素研究[J].国际病毒学杂志,2016,23(1):26-28.
    [4] WU JF,CHANG MH.Natural history of chronic hepatitis B virus infection from infancy to adult life-the mechanism of inflammation triggering and long-term impacts[J].J Biomed Sci,2015,22(1):92.
    [5]LIAW YF,KAO JH,PIRATVISUTH T,et al.Asian-Pacific consensus statement on the management of chronic hepatitis B:a 2012 update[J].Hepatol Int,2012,6(3):531-561.
    [6]MARTIN P,LAU DT,NGUYEN MH,et al.A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States:2015 Update[J].Clin Gastroenterol Hepatol,2015,13(12):2071-2087.
    [7]PARK JY,PARK YN,KIM DY,et al.High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels[J].J Viral Hepat,2008,15(8):615-621.
    [8] CHEONG JY,KIM D J,HWANG SG,et al.Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels[J].Liver Int,2011,31(9):1352-1358.
    [9] ALAM MM,MAHTAB MA,AKBAR SM,et al.Hepatic necroinflammation and severe liver fibrosis in patients with chronic hepatitis B with undetectable HBV DNA and persistently normal alanine aminotransferase[J].Bangladesh Med Res Counc Bull,2014,40(3):92-96.
    [10]XIANG TX,TAO XP,LI XN,et al.Study on interferon gamma spot level of chronic hepatitis B infection in different immune stages and optimal opportunity of antiviral treatment in low levels of ALT patients[J].Int J Virol,2015,22(3):157-161.(in Chinese)向天新,陶学萍,李细女,等.慢性乙肝病毒感染者不同免疫阶段IFN-γ斑点水平及其他低丙氨酸氨基转移酶抗病毒治疗中的作用[J].国际病毒学杂志,2015,22(3):157-161.
    [11] Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B(2010 verson)[J].J Clin Hepatol,2011,27(1):Ⅰ-ⅩⅥ.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版)[J].临床肝胆病杂志,2011,27(1):Ⅰ-ⅩⅥ.
    [12]Chinese Society of Hepatology and Chinese Society of Infectious Diseases and Parasitic Disease,Chinese Medical Association.Guideline:prevention and treatment of viral hepatitis(draft)[J].Chin JHepatol,2000,8(6):324-329.(in Chinese)中华医学会传染病与寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329.
    [13]MYERS RP,TAINTURIER MH,RATZIU V,et al.Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B[J].J Hepatol,2003,39(2):222-230.
    [14]BENINI F,PIGOZZI MG,BAISINI O,et al.Increased serum gamma-glutamyl-transpeptidase concentration is associated with nonalcoholic steatosis and not with cholestasis in patients with chronic hepatitis C[J].J Gastroenterol Hepatol,2007,22(10):1621-1626.
    [15] KRISHNAMURTHY HA.The serum gamma glutamyl transpeptidasea non invasive diagnostic bio marker of chronic anicteric non alcoholic liver diseases[J].J Clin Diagn Res,2013,7(4):691-694.
  • Cited by

    Periodical cited type(7)

    1. 余文君,余婷婷,李丽华,王红英,普冬,杨永锐. 血清HBsAg、HBV RNA、GGT及GPR联合检测对慢性HBV感染自然史的诊断价值. 昆明医科大学学报. 2024(07): 99-104 .
    2. 王娟霞,陈馨悦,魏世博,孙新策,朱浩宇,连唐悠悠,杜雨峰. 慢性乙型肝炎患者肝脏炎症程度预测模型的研究. 中国实用内科杂志. 2023(05): 390-395 .
    3. 卢瑾. ALT、AST、ALP对病毒性肝炎患者病情发生发展的影响研究. 标记免疫分析与临床. 2020(01): 67-69+95 .
    4. 李福华,刘雯. 恩替卡韦联合苦黄注射液对ALT<2×ULN的HBeAg阴性慢性乙型肝炎患者凝血-纤溶功能、免疫炎症及肝脏硬度的影响. 现代中西医结合杂志. 2019(15): 1634-1637 .
    5. 阮建文,高丽娟,苏汝开,王亚娇,杨京. 核苷(酸)类似物治疗慢性乙型肝炎急性发作的效果观察. 临床肝胆病杂志. 2019(06): 1251-1255 . 本站查看
    6. 张雪珍,谢能文,邹波,钟青梅,章萍,熊墨龙,何金秋,肖影群. 轻微转氨酶升高慢性乙型肝炎患者抗病毒治疗的研究. 当代医学. 2019(24): 58-60 .
    7. 崔红权. 血清ALT、AST、GGT检测在肝脏疾病诊断中应用研究. 国际检验医学杂志. 2017(16): 2293-2295 .

    Other cited types(1)

  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2368) PDF downloads(512) Cited by(8)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return